Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £266 million in external investment has been raised by Oxford University Innovation spinouts since 2000, and five are currently listed on London’s AIM market.

The creation of these new spinout companies also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2015

Domain-centric intelligent automated data extraction methodology.

Incorporated in February 2015

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

2014

At OxSyBio, we are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Our vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.

Professor Bayley’s group have previously demonstrated the ability to print three-dimensional networks comprising tens of thousands of picoliter aqueous droplets forming a cohesive material. These networks can be built in software-controlled geometries using a number of different droplet types, thus enabling them to perform simple cell-like functions and act as ‘tissue-like’ materials. Initial work showed that printed networks were capable of conducting electrical signals along neuron-like pathways by the selective incorporation of membrane proteins, or to fold in a pre-defined manner to assume altered shapes after printing.

OxSyBio is refining and advancing this technology to print more complex networks more rapidly and at a higher resolution. We are also adapting the approach to print living cells inside droplets, which will enable the direct printing of 3D cell networks with many of the characteristics of living tissues.

Incorporated in April 2014

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Incorporated in April 2014

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

Incorporated in March 2014

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Contact: James Mallinson

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

Incorporated in January 2014

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.

Incorporated in January 2014

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

A private biopharmaceutical company focused on the development of therapies for retinal dystrophies.

Incorporated in January 2014

Origin: Oxford University, Nuffield Department of Clinical Neurosciences

Contact: James Mallinson

2013

Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.

Incorporated in September 2013

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.

Incorporated in April 2013

Origin: Oxford University, Department of Cardiovascular Medicine

Contact: James Mallinson

2012

Offering the most accurate assessment of running biomechanics that modern science is able to provide.

Incorporated in December 2012

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Cellular immunity vaccines.

Incorporated in September 2012

Origin: Oxford University, Weatherall Institute of Molecular Medicine

Contact: James Mallinson

Revolutionary healthcare technology that measures medical vital signs without physical contact.

Incorporated in August 2012

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.

Incorporated in July 2012

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

2011

Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Incorporated in October 2011

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.

Incorporated in September 2011

Origin: Oxford University, Department of Classics

Contact: James Mallinson

Tissue expander solutions for the primary use in reconstructive and dental surgery.

Incorporated in July 2011

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Advanced materials and technologies in safe, lightweight, high performance hydrogen storage technology.

Incorporated in January 2011

Origin: Oxford University, Science and Technology Facilities Council

Contact: James Mallinson

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation